BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang K, Guo C, Zou S, Yu Y, Fan X, Wang B, Liu M, Fang L, Chen D. Synthesis, characterization and in vitro/in vivo evaluation of novel reduction-sensitive hybrid nano-echinus-like nanomedicine. Artif Cells Nanomed Biotechnol 2018;46:659-67. [PMID: 29703084 DOI: 10.1080/21691401.2018.1466147] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhu D, Zhang Q, Chen Y, Xie M, Li J, Yao S, Li M, Lou Z, Cai Y, Sun X. Mechanochemical preparation of triptolide-loaded self-micelle solid dispersion with enhanced oral bioavailability and improved anti-tumor activity. Drug Deliv 2022;29:1398-408. [PMID: 35532137 DOI: 10.1080/10717544.2022.2069879] [Reference Citation Analysis]
2 Mollazadeh S, Mackiewicz M, Yazdimamaghani M. Recent advances in the redox-responsive drug delivery nanoplatforms: A chemical structure and physical property perspective. Mater Sci Eng C Mater Biol Appl 2021;118:111536. [PMID: 33255089 DOI: 10.1016/j.msec.2020.111536] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
3 Jiang X, Lin M, Huang J, Mo M, Liu H, Jiang Y, Cai X, Leung W, Xu C. Smart Responsive Nanoformulation for Targeted Delivery of Active Compounds From Traditional Chinese Medicine. Front Chem 2020;8:559159. [PMID: 33363102 DOI: 10.3389/fchem.2020.559159] [Reference Citation Analysis]
4 Zhang Q, Li J, Zu W, Yang H, Wang Y. One-pot synthesis of Eu-MOFs for bioimaging and drug delivery. Drug Dev Ind Pharm 2021;:1-8. [PMID: 34612119 DOI: 10.1080/03639045.2021.1988100] [Reference Citation Analysis]
5 Guo C, Hou X, Liu Y, Zhang Y, Xu H, Zhao F, Chen D. Novel Chinese Angelica Polysaccharide Biomimetic Nanomedicine to Curcumin Delivery for Hepatocellular Carcinoma Treatment and Immunomodulatory Effect. Phytomedicine 2021;80:153356. [PMID: 33039729 DOI: 10.1016/j.phymed.2020.153356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Jin Y, Wang Y, Liu X, Zhou J, Wang X, Feng H, Liu H. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers. Drug Des Devel Ther 2020;14:5205-15. [PMID: 33268983 DOI: 10.2147/DDDT.S260253] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Liu M, Wang B, Guo C, Hou X, Cheng Z, Chen D. Novel multifunctional triple folic acid, biotin and CD44 targeting pH-sensitive nano-actiniaes for breast cancer combinational therapy. Drug Deliv 2019;26:1002-16. [PMID: 31571501 DOI: 10.1080/10717544.2019.1669734] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
8 Wang B, Zhang W, Zhou X, Liu M, Hou X, Cheng Z, Chen D. Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer. Drug Deliv 2019;26:1265-79. [PMID: 31777307 DOI: 10.1080/10717544.2019.1693707] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
9 Hou X, Lin H, Zhou X, Cheng Z, Li Y, Liu X, Zhao F, Zhu Y, Zhang P, Chen D. Novel dual ROS-sensitive and CD44 receptor targeting nanomicelles based on oligomeric hyaluronic acid for the efficient therapy of atherosclerosis. Carbohydr Polym 2020;232:115787. [PMID: 31952595 DOI: 10.1016/j.carbpol.2019.115787] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
10 Song J, Liu Y, Lin L, Zhao Y, Wang X, Zhong M, Xie T, Luo Y, Li S, Yang R, Li H. Glycyrrhetinic acid modified and pH-sensitive mixed micelles improve the anticancer effect of curcumin in hepatoma carcinoma cells. RSC Adv 2019;9:40131-45. [DOI: 10.1039/c9ra07250k] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Wang B, Guo C, Liu Y, Han G, Li Y, Zhang Y, Xu H, Chen D. Novel nano-pomegranates based on astragalus polysaccharides for targeting ERα-positive breast cancer and multidrug resistance. Drug Deliv 2020;27:607-21. [PMID: 32308054 DOI: 10.1080/10717544.2020.1754529] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]